Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 14, 2012Inflammatory Bowel DiseasesOpen Access

Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates

View Full Paper
Ask AI
Bookmark
Share

Authors

EFEric R. FedykTakeda (United States)TWTim WyantUniversity of ArizonaVCVilmos CsizmadiaAkebia Therapeutics (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fedyk et al. (2012) studied this question.

synapsesocial.com/papers/6a815ab60914b5fb8de3fcffhttps://doi.org/10.1002/ibd.22940
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1The monoclonal anti–VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans2008 · 190 citations